Dr. Hao Wang
Assistant Professor of Oncology
Division of Oncology Biostatistics and Bioinformatics
BS, Chemistry, Wuhan University PhD, Biostatistics, University of Pennsylvania
Hao Wang is an Assistant Professor of Oncology. She received her Ph.D. in Biostatistics from the University of Pennsylvania in 2009 and joined the faculty in the Division of Biostatistics of the Sidney Kimmel Comprehensive Cancer Center the same year. Prior to her doctoral studies, she served as a statistician at the Center for Clinical Epidemiology and Biostatics at the University of Pennsylvania and as a research biostatistician at the Fox Chase Cancer Center.
Dr. Wang is interested in developing statistical methods to address problems in biomedical research. Her areas of research include methods for longitudinal data, missing or coarsened data, causal inference, and early phase clinical trial designs. Her current research focuses on latent variable models and Bayesian methods for the analysis of longitudinal data with missing observations and measurement errors. She was awarded a grant from the Maryland Cigarette Restitution Fund to develop methods to study the longitudinal smoking patterns and the self-reporting behaviors of smokers. She has an extensive collaborative experience in translational and clinical cancer research, cancer prevention and control, as well as AIDS and kidney disease. She provides statistical support through the Kimmel Canter Center Shared Resources.
Wang H, and Heitjan DF. (2008) Modeling heaping in self-reported cigarette counts. Statistics in Medicine, 27:3789¬¬¬¬-3804
Xie D, Joffe MM, Brunelli SM, Beck G, Chertow GM, Fink JC, Greene T, Hsu CY, Kusek JW, Landis R, Lash J, Levey AS, O'Conner A, Ojo A, Rahman M, Townsend RR, Wang H, and Feldman HI. (2008) A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease. Clinical Journal of the American Society of Nephrology, 3:1332-1338
Gross R, Bilker WB, Wang H, and Chapman J. (2008) How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART? HIV Clinical Trials, 9:202-206.
Holmes WC, Bilker WB, Wang H, Chapman J, and Gross R. HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. Journal of Acquired Immune Deficiency Syndromes. 2007; 46:323-327.
Mohler ER 3rd, Wang H, Medenilla E, and Scott C. (2007) Effect of statin treatment on aortic valve and coronary artery calcification. Journal of Heart Valve Disease, 16:378-386.
Mohler ER 3rd, Lech G, Supple GE, Wang H, and Chance B. (2006) Impaired exercise-induced blood volume in type 2 diabetes with or without peripheral arterial disease measured by continuous-wave near-infrared spectroscopy. Diabetes Care, 29:1856-1859.
Sundermeyer ML, Meropol NJ, Rogatko A, Wang H, and Cohen SJ. (2005) Changing patterns of bone and brain metastases in patients with colorectal cancer. Clinical Colorectal Cancer, 5:108-113.
Schonll RA, Rothman RL, Wielt DB, Lerman C, Pedri H, Wang H, Babb J, Miller SM, Movsas B, Sherman E, Ridge JA, Uger M, Langer C, Goldberg M, Scott W, and Cheng J. (2005) A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients. Annals of Behavioral Medicine, 30:1-11.
Cooper HS, Chang WC, Coudry R, Gary MA, Everley L, Spittle CS, Wang H, Litwin S, and Clapper ML. (2005) Generation of a unique strain of multiple intestinal neoplasia (Apc(+/Min-FCCC)) mice with significantly increased numbers of colorectal adenomas. Molecular Carcinogenesis, 44:31-41.
Berger AC, Farma J, Scott WJ, Freedman G, Weiner L, Cheng JD, Wang H, and Goldberg M. (2005) Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved Survival. Journal of Clinical Oncology, 23:4330-4337.
Carlini LE, Meropol NJ, Bever J, Andria ML, Hill T, Gold P, Rogatko A, Wang H, and Blanchard RL. (2005) UGT1A7 and UGT1A9 Polymorphisms Predict Response and Toxicity in Colorectal Cancer Patients Treated with Capecitabine/Irinotecan. Clinical Cancer Research, 11:1226-1236.
Cheng JD, Valianou M, Canutescu AA, Jaffe EK, Lee HO, Wang H, Lai JH, Bachovchin WW, and Weiner LM. (2005) Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth. Molecular Cancer Therapeutics, 4:351-360.
Rogatko A, Babb JS, Wang H, Slifker MJ, and Hudes GR. (2004) Patient Characteristics Compete with Dose as Predictors of Acute Treatment Toxicity in Early Phase Clinical Trials. Clinical Cancer Research, 10:4645-4651.
Lui YW, Macari M, Israel G, Bini EJ, Wang H, and Babb J. (2003) Effect of different slice thickness on CT colonography data interpretation: preliminary observations. Radiology, 229:791-797.
Cohen SJ, Ho L, Ranganathan S, Abbruzzese JL, Alpaugh RK, Beard M, Lewis NL, McLaughlin S, Rogatko A, Perez-Ruixo JJ, Thistle AM, Verhaeghe T, Wang H, Weiner LM, Wright JJ, Hudes GR, and Meropol NJ. (2003) Phase II and pharmacodynamic study of the Farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma. Journal of Clinical Oncology, 21:1301-1306.
Wang H, Tseng K, and Lebrilla CB. (1999) A general method for producing bio-affinity MALDI probes. Analytical Chemistry, 71:2014-2020.